KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Intangibles (2016 - 2025)

Historic Intangibles for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $7.7 million.

  • West Pharmaceutical Services' Intangibles fell 2870.37% to $7.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $7.7 million, marking a year-over-year decrease of 2870.37%. This contributed to the annual value of $7.7 million for FY2025, which is 2870.37% down from last year.
  • As of Q4 2025, West Pharmaceutical Services' Intangibles stood at $7.7 million, which was down 2870.37% from $8.9 million recorded in Q3 2025.
  • In the past 5 years, West Pharmaceutical Services' Intangibles registered a high of $28.7 million during Q1 2021, and its lowest value of $7.7 million during Q4 2025.
  • Over the past 5 years, West Pharmaceutical Services' median Intangibles value was $16.2 million (recorded in 2023), while the average stood at $16.8 million.
  • Per our database at Business Quant, West Pharmaceutical Services' Intangibles skyrocketed by 213.52% in 2021 and then plummeted by 3065.13% in 2022.
  • Over the past 5 years, West Pharmaceutical Services' Intangibles (Quarter) stood at $23.0 million in 2021, then dropped by 20.0% to $18.4 million in 2022, then dropped by 17.93% to $15.1 million in 2023, then dropped by 28.48% to $10.8 million in 2024, then decreased by 28.7% to $7.7 million in 2025.
  • Its last three reported values are $7.7 million in Q4 2025, $8.9 million for Q3 2025, and $9.7 million during Q2 2025.